Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome.
dc.contributor.author | Kulke, M | |
dc.contributor.author | Hörsch, D | |
dc.contributor.author | Caplin, M | |
dc.contributor.author | Anthony, L | |
dc.contributor.author | Bergsland, E | |
dc.contributor.author | Oberg, K | |
dc.contributor.author | Welin, S | |
dc.contributor.author | Warner, R | |
dc.contributor.author | Bohas, C | |
dc.contributor.author | Kunz, P | |
dc.contributor.author | Grande, E | |
dc.contributor.author | Valle, Juan W | |
dc.contributor.author | Lapuerta, P | |
dc.contributor.author | Banks, P | |
dc.contributor.author | Jackson, S | |
dc.contributor.author | Jiang, W | |
dc.contributor.author | Biran, T | |
dc.contributor.author | Pavel, M | |
dc.date.accessioned | 2017-04-19T17:04:41Z | |
dc.date.available | 2017-04-19T17:04:41Z | |
dc.date.issued | 2016-10-01 | |
dc.identifier.citation | Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome. 2016, 27(suppl_6):422PD Annals of Oncology | en |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdw369.07 | |
dc.identifier.uri | http://hdl.handle.net/10541/620257 | |
dc.language.iso | en | en |
dc.relation.url | https://academic.oup.com/annonc/article/2799161/Integrated | en |
dc.rights | Archived with thanks to Annals of Oncology | en |
dc.title | Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome. | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Medical Oncology, Dana-Farber Cancer Institute, Boston | en |
dc.identifier.journal | Annals of Oncology | en |